209 related articles for article (PubMed ID: 14500570)
1. Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity.
Ruderman NB; Saha AK; Kraegen EW
Endocrinology; 2003 Dec; 144(12):5166-71. PubMed ID: 14500570
[TBL] [Abstract][Full Text] [Related]
2. Role of malonyl-CoA in heart disease and the hypothalamic control of obesity.
Folmes CD; Lopaschuk GD
Cardiovasc Res; 2007 Jan; 73(2):278-87. PubMed ID: 17126822
[TBL] [Abstract][Full Text] [Related]
3. AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats.
Assifi MM; Suchankova G; Constant S; Prentki M; Saha AK; Ruderman NB
Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E794-800. PubMed ID: 15956049
[TBL] [Abstract][Full Text] [Related]
4. LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle.
Thomson DM; Brown JD; Fillmore N; Condon BM; Kim HJ; Barrow JR; Winder WW
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1572-9. PubMed ID: 17925454
[TBL] [Abstract][Full Text] [Related]
5. Control of hepatic fatty acid oxidation by 5'-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism.
Velasco G; Geelen MJ; Guzmán M
Arch Biochem Biophys; 1997 Jan; 337(2):169-75. PubMed ID: 9016810
[TBL] [Abstract][Full Text] [Related]
6. AMP-activated protein kinase regulation of fatty acid oxidation in the ischaemic heart.
Hopkins TA; Dyck JR; Lopaschuk GD
Biochem Soc Trans; 2003 Feb; 31(Pt 1):207-12. PubMed ID: 12546686
[TBL] [Abstract][Full Text] [Related]
7. Acute regulation of fatty acid oxidation and amp-activated protein kinase in human umbilical vein endothelial cells.
Dagher Z; Ruderman N; Tornheim K; Ido Y
Circ Res; 2001 Jun; 88(12):1276-82. PubMed ID: 11420304
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome: adenosine monophosphate-activated protein kinase and malonyl coenzyme A.
Ruderman NB; Saha AK
Obesity (Silver Spring); 2006 Feb; 14 Suppl 1():25S-33S. PubMed ID: 16642960
[TBL] [Abstract][Full Text] [Related]
9. Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA.
Lane MD; Wolfgang M; Cha SH; Dai Y
Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S49-54. PubMed ID: 18719599
[TBL] [Abstract][Full Text] [Related]
10. Malonyl CoA control of fatty acid oxidation in the newborn heart in response to increased fatty acid supply.
Onay-Besikci A; Sambandam N
Can J Physiol Pharmacol; 2006 Nov; 84(11):1215-22. PubMed ID: 17218986
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle.
Cha SH; Hu Z; Chohnan S; Lane MD
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14557-62. PubMed ID: 16203972
[TBL] [Abstract][Full Text] [Related]
12. Targeting intermediary metabolism in the hypothalamus as a mechanism to regulate appetite.
Lopaschuk GD; Ussher JR; Jaswal JS
Pharmacol Rev; 2010 Jun; 62(2):237-64. PubMed ID: 20392806
[TBL] [Abstract][Full Text] [Related]
13. Increased malonyl-CoA and diacylglycerol content and reduced AMPK activity accompany insulin resistance induced by glucose infusion in muscle and liver of rats.
Kraegen EW; Saha AK; Preston E; Wilks D; Hoy AJ; Cooney GJ; Ruderman NB
Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E471-9. PubMed ID: 16234268
[TBL] [Abstract][Full Text] [Related]
14. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
[TBL] [Abstract][Full Text] [Related]
15. AMPK expression and phosphorylation are increased in rodent muscle after chronic leptin treatment.
Steinberg GR; Rush JW; Dyck DJ
Am J Physiol Endocrinol Metab; 2003 Mar; 284(3):E648-54. PubMed ID: 12441311
[TBL] [Abstract][Full Text] [Related]
16. AMPK and ACC phosphorylation: effect of leptin, muscle fibre type and obesity.
Janovská A; Hatzinikolas G; Staikopoulos V; McInerney J; Mano M; Wittert GA
Mol Cell Endocrinol; 2008 Mar; 284(1-2):1-10. PubMed ID: 18255222
[TBL] [Abstract][Full Text] [Related]
17. Regulation of energy metabolism by long-chain fatty acids.
Nakamura MT; Yudell BE; Loor JJ
Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
[TBL] [Abstract][Full Text] [Related]
18. Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise.
Park H; Kaushik VK; Constant S; Prentki M; Przybytkowski E; Ruderman NB; Saha AK
J Biol Chem; 2002 Sep; 277(36):32571-7. PubMed ID: 12065578
[TBL] [Abstract][Full Text] [Related]
19. Influence of malonyl-CoA and palmitate concentration on rate of palmitate oxidation in rat muscle.
Merrill GF; Kurth EJ; Rasmussen BB; Winder WW
J Appl Physiol (1985); 1998 Nov; 85(5):1909-14. PubMed ID: 9804598
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo.
Saha AK; Avilucea PR; Ye JM; Assifi MM; Kraegen EW; Ruderman NB
Biochem Biophys Res Commun; 2004 Feb; 314(2):580-5. PubMed ID: 14733947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]